ALS company profile

ALQ · ASX · AUD

Compare ALS
$19.30Change from previous close: −4.36%Absolute change: −$0.88

Close · November 20, 2026

Company profile

ALS has 23,342 employees and is headquartered in Brisbane, Australia.

Mining and mineral exploration companies, coal producers, governments, and consulting and engineering firms are among the customers of ALS Limited, which also serves the environmental, food, pharmaceutical and consumer goods markets. The Australian group operates in Africa, the Middle East, Europe and the United States, among other regions. Its Commodities segment provides assaying, analytical testing and metallurgical services, along with coal sampling and certification, and covers the resource life cycle from exploration to rehabilitation. The Life Sciences segment offers analytical testing, sampling and remote monitoring, together with microbiological, physical and chemical testing.

In the fiscal year ended March 2026, revenue reached AUD 3.3 billion, up 10.7% from the prior year, and net profit came to AUD 318.7 million. The group employs 23,342 people. Established in 1863, it has its headquarters in Brisbane, Australia.

Company facts

Industry
Consulting Services
Country
Australia
Headquarters
25 King Street, 4006, Brisbane
Employees
23,342
Chief executive
Malcolm Deane
Founded
1863
Fiscal year
April - March
Listing
ALQ · ASX
Currency
AUD
ISIN
AU000000ALQ6

ALS and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
ALSALQAustralia$6.53B23,34217.1%32.2
Baycurrent6532Japan$11.84B6,78833.3%46.1
Booz Allen Hamilton HoldingBAHUnited States$9.61B31,0009.6%12.6
Bureau VeritasBVIFrance$14.43B78,84915.6%26.3
EquifaxEFXUnited States$20.73B15,00019.2%28.7
SGSSGSNSwitzerland$23.98B83,00014.1%29.9

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare ALS with its competitors